HalozymeTherapeutics HALO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSIHalozyme Therapeutics HALO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NASDAQ stock exchange
operates under Health Care sector & deals in Biotechnology Biological Products No Diagnostic Substances
Daily price and charts and targets HalozymeTherapeutics Strong Daily Stock price targets for HalozymeTherapeutics HALO are 60.73 and 62.8 | Daily Target 1 | 59.12 | | Daily Target 2 | 60.26 | | Daily Target 3 | 61.193333333333 | | Daily Target 4 | 62.33 | | Daily Target 5 | 63.26 |
Daily price and volume Halozyme Therapeutics
| Date |
Closing |
Open |
Range |
Volume |
Mon 14 April 2025 |
61.39 (1.94%) |
61.30 |
60.06 - 62.13 |
0.8604 times |
Fri 11 April 2025 |
60.22 (4.37%) |
57.87 |
57.40 - 60.88 |
0.9821 times |
Thu 10 April 2025 |
57.70 (-4.86%) |
59.19 |
56.68 - 59.64 |
1.0639 times |
Wed 09 April 2025 |
60.65 (5.4%) |
56.11 |
55.71 - 61.44 |
1.1043 times |
Tue 08 April 2025 |
57.54 (-3.05%) |
60.87 |
56.93 - 61.37 |
1.0802 times |
Mon 07 April 2025 |
59.35 (-0.7%) |
57.50 |
56.38 - 61.81 |
1.0866 times |
Fri 04 April 2025 |
59.77 (-3.47%) |
60.72 |
59.11 - 60.98 |
1.2255 times |
Thu 03 April 2025 |
61.92 (-1.75%) |
62.07 |
61.23 - 63.14 |
1.0054 times |
Wed 02 April 2025 |
63.02 (1.86%) |
61.70 |
61.54 - 63.14 |
0.8401 times |
Tue 01 April 2025 |
61.87 (-3.04%) |
64.06 |
61.43 - 64.17 |
0.7516 times |
Mon 31 March 2025 |
63.81 (-0.05%) |
63.39 |
62.60 - 64.07 |
0.8764 times |
Weekly price and charts HalozymeTherapeutics Strong weekly Stock price targets for HalozymeTherapeutics HALO are 60.73 and 62.8 | Weekly Target 1 | 59.12 | | Weekly Target 2 | 60.26 | | Weekly Target 3 | 61.193333333333 | | Weekly Target 4 | 62.33 | | Weekly Target 5 | 63.26 |
Weekly price and volumes for Halozyme Therapeutics
| Date |
Closing |
Open |
Range |
Volume |
Mon 14 April 2025 |
61.39 (1.94%) |
61.30 |
60.06 - 62.13 |
0.2399 times |
Fri 11 April 2025 |
60.22 (0.75%) |
57.50 |
55.71 - 61.81 |
1.4824 times |
Fri 04 April 2025 |
59.77 (-6.38%) |
63.39 |
59.11 - 64.17 |
1.31 times |
Fri 28 March 2025 |
63.84 (-2.03%) |
65.69 |
62.72 - 66.00 |
0.7368 times |
Fri 21 March 2025 |
65.16 (4.64%) |
62.46 |
60.92 - 65.21 |
1.462 times |
Fri 14 March 2025 |
62.27 (2.12%) |
60.17 |
60.14 - 63.11 |
1.0223 times |
Fri 07 March 2025 |
60.98 (3.09%) |
59.14 |
56.90 - 61.49 |
1.1687 times |
Fri 28 February 2025 |
59.15 (2.42%) |
57.93 |
57.45 - 59.35 |
0.8485 times |
Fri 21 February 2025 |
57.75 (-0.93%) |
58.84 |
56.07 - 60.67 |
1.0028 times |
Fri 14 February 2025 |
58.29 (2.08%) |
57.10 |
56.51 - 59.40 |
0.7267 times |
Fri 07 February 2025 |
57.10 (0.81%) |
55.12 |
54.96 - 58.20 |
0.7467 times |
Monthly price and charts HalozymeTherapeutics Strong monthly Stock price targets for HalozymeTherapeutics HALO are 54.32 and 62.78 | Monthly Target 1 | 51.96 | | Monthly Target 2 | 56.68 | | Monthly Target 3 | 60.423333333333 | | Monthly Target 4 | 65.14 | | Monthly Target 5 | 68.88 |
Monthly price and volumes Halozyme Therapeutics
| Date |
Closing |
Open |
Range |
Volume |
Mon 14 April 2025 |
61.39 (-3.79%) |
64.06 |
55.71 - 64.17 |
0.6518 times |
Mon 31 March 2025 |
63.81 (7.88%) |
59.14 |
56.90 - 66.00 |
1.0835 times |
Fri 28 February 2025 |
59.15 (4.43%) |
55.12 |
54.96 - 60.67 |
0.7773 times |
Fri 31 January 2025 |
56.64 (18.47%) |
48.23 |
47.52 - 57.46 |
1.1005 times |
Tue 31 December 2024 |
47.81 (0.04%) |
48.20 |
46.39 - 49.79 |
0.7354 times |
Tue 26 November 2024 |
47.79 (-5.5%) |
55.66 |
42.01 - 62.13 |
1.6575 times |
Thu 31 October 2024 |
50.57 (-11.65%) |
56.97 |
48.84 - 62.00 |
1.0706 times |
Mon 30 September 2024 |
57.24 (-10.35%) |
63.59 |
55.43 - 64.18 |
0.9224 times |
Fri 30 August 2024 |
63.85 (15.54%) |
55.52 |
51.46 - 65.53 |
1.0402 times |
Wed 31 July 2024 |
55.26 (5.54%) |
52.23 |
50.68 - 57.09 |
0.9607 times |
Fri 28 June 2024 |
52.36 (18.22%) |
44.39 |
43.63 - 53.00 |
1.1017 times |
DMA SMA EMA moving averages of Halozyme Therapeutics HALO
DMA (daily moving average) of Halozyme Therapeutics HALO
| DMA period | DMA value | | 5 day DMA | 59.5 | | 12 day DMA | 60.92 | | 20 day DMA | 62.02 | | 35 day DMA | 60.89 | | 50 day DMA | 59.85 | | 100 day DMA | 55.45 | | 150 day DMA | 55.86 | | 200 day DMA | 55.78 | EMA (exponential moving average) of Halozyme Therapeutics HALO
| EMA period | EMA current | EMA prev | EMA prev2 | | 5 day EMA | 60.2 | 59.6 | 59.29 | | 12 day EMA | 60.66 | 60.53 | 60.59 | | 20 day EMA | 60.89 | 60.84 | 60.9 | | 35 day EMA | 60.4 | 60.34 | 60.35 | | 50 day EMA | 59.49 | 59.41 | 59.38 |
SMA (simple moving average) of Halozyme Therapeutics HALO
| SMA period | SMA current | SMA prev | SMA prev2 | | 5 day SMA | 59.5 | 59.09 | 59 | | 12 day SMA | 60.92 | 61.13 | 61.44 | | 20 day SMA | 62.02 | 62.01 | 62.04 | | 35 day SMA | 60.89 | 60.77 | 60.7 | | 50 day SMA | 59.85 | 59.74 | 59.66 | | 100 day SMA | 55.45 | 55.43 | 55.44 | | 150 day SMA | 55.86 | 55.87 | 55.9 | | 200 day SMA | 55.78 | 55.72 | 55.67 |
|
|
